Behrenbruch Christian - 12 Nov 2024 SCHEDULE 13G Report for Telix Pharmaceuticals Ltd Ordinary Shares (TLX)

Filing Manager
Behrenbruch Christian
Reporting Manager
Behrenbruch Christian
Security
Telix Pharmaceuticals Ltd Ordinary Shares
Symbol
TLX
Shares outstanding
334,705,968 shares
Disclosed Ownership
23,329,006 shares
Ownership
7%
Form type
SCHEDULE 13G
Filing time
14 Feb 2025, 07:00:11 UTC
Date of event
12 Nov 2024
SEC
View on sec.gov

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Behrenbruch Christian 7% 23,329,006 654,006 22,675,000 /s/ Dr. Christian Behrenbruch Behrenbruch Christian
Elk River Holdings Pty Ltd 6.8% 22,675,000 0 22,675,000 /s/ Dr. Christian Behrenbruch Dr. Christian Behrenbruch/Director